Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES. Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
Founded in 1984, Labcor is a world-renowned company that specializes in the manufacturing of biological prosthesis. Located in Belo Horizonte/Brazil,
the company is a national leader in the supply of cardiovascular Bioprosthesis and has already achieved over 150.000 implants of its hearts valves throughout the world.
Labcor, which annually produces in excess of 20,000 heart valves and grafts, is present throughout Brazil and has offices in Rio de Janeiro, São Paulo, Belo Horizonte,
as well as representatives or distributors in other capital cities. Today the company exports its products to several countries such as Germany, Belgium, Argentina,
Colombia,France, Italy, Austria, Spain, Portugal and other markets throughout the region and Asia.
Ever since Labcor produced it first heart valve, the company has been developing cardiovascular and vascular implantable devices.This experience has allowed the company
to develop a portfolio rich in biotechnological products.
Today, Labcor is in the vanguard of scientific research in the development and improvements bioprosthetic devices, scientifically searching for solutions to save more lives.
Our researchersshare their knowledge and discoveries of their clinical tests by publishing in specialized periodicals and medical conventions, which makes Labcor one
of the most outstanding cardiovascular companies in this sector.
By validating joint efforts to implement total quality, Labcor has received certification for Good Practices in Medical Products Manufacturing (GMP) granted by Anvisa, and
the ISO 13485:2003 accredited by international associations, as well as being the only company in this sector in Latin America with the CE mark for several products.
We are always under detailed evaluations and constantly perfecting our products in order to create hope for a more healthy life for the patients that receive them.
All of Labcor′s efforts, together with the quality of the manufacturing environment and the commitment of its employees make our products an ideal alternative for the patient.
With dedication and integrity we have made our work more dignifying and endorse our commitment to life.